Zoetis (ZTS) Depreciation & Amortization (IS) (2017 - 2021)

Zoetis (ZTS) reported Depreciation & Amortization (IS) of $109.0 million for Q1 2021, down 0.91% year-over-year from $110.0 million in Q1 2020, and down 1.8% quarter-over-quarter from $111.0 million in Q3 2020.

Zoetis (ZTS) Depreciation & Amortization (IS) (2017 - 2021) Analysis & Trends

Zoetis (ZTS) has 5 years of Depreciation & Amortization (IS) data on file, last reported at $109.0 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 1.88 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 109.00 Mn
Sep 30, 2020 111.00 Mn
Jun 30, 2020 111.00 Mn
Mar 31, 2020 110.00 Mn
Sep 30, 2019 107.00 Mn
Jun 30, 2019 98.00 Mn
Mar 31, 2019 98.00 Mn
Sep 30, 2018 84.00 Mn
Jun 30, 2018 63.00 Mn
Mar 31, 2018 60.00 Mn
Oct 1, 2017 58.00 Mn
Jul 2, 2017 59.00 Mn
Apr 2, 2017 62.00 Mn